0000000000269858

AUTHOR

I. Martinez-mir

showing 2 related works from this author

Estudio de la relación entre adherencia a la Escuela de la Espalda y afrontamiento del dolor en pacientes con lumbalgia crónica

2019

Resumen Introduccion La Escuela de la Espalda (EE) es un tratamiento en pacientes con lumbalgia cronica con contenidos educativos asociados a otras medidas terapeuticas como ejercicios. Es eficaz si se realiza y es bien conocido que las modificaciones en los habitos diarios son dificiles de cumplir. Este trabajo de investigacion evalua si los pacientes que al terminar la EE tienen un predominio de estrategias activas en su afrontamiento del dolor se adhieren mejor a las ensenanzas de la EE. Material y metodo Estudio observacional prospectivo para valorar la adherencia a la EE en pacientes con dolor lumbar cronico. Se incluyeron pacientes adultos que aceptaban realizar la EE. Se excluyeron a…

Exercici terapèutic030506 rehabilitation03 medical and health sciences0302 clinical medicineRehabilitacióRehabilitationPhysical Therapy Sports Therapy and RehabilitationLumbàlgia0305 other medical science030217 neurology & neurosurgery
researchProduct

Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial

2018

Background: The long-term efficacy of corticosteroids to prevent atopic dermatitis (AD) relapses has partially been addressed in children. This study compared an intermittent dosing regimen of fluticasone propionate (FP) cream 0.05% with its vehicle base in reducing the risk of relapse in children with stabilized AD. Methods A randomized controlled, multicentric, double-blind trial was conducted. Children (2-10 years) with mild/moderate AD (exclusion criteria: > 30% affected body surface area and/or head) were enrolled into an Open-label Stabilization Phase (OSP) of up to 2 weeks on twice daily FP. Those who achieved treatment success entered the Double-blind Maintenance Phase (DMP). They w…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyImmunologyAnti-Inflammatory AgentsLower riskFluticasone propionateIntermittent dosingFluticasone propionateDermatitis Atopiclaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallaw030225 pediatricsInternal medicineSecondary PreventionmedicineAtopic dermatitis Clinical trial Fluticasone propionate Intermittent dosing PreventionHumansImmunology and AllergyChildFluticasoneAtopic dermatitisBody surface areabusiness.industryPreventionGeneral MedicineAtopic dermatitismedicine.diseaseClinical trialRegimenChild PreschoolRelative riskFluticasoneFemalebusinessmedicine.drug
researchProduct